Clinical Trial Update: Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALL [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/phase 3 trial evaluated clofarabine or high-dose cytarabine in combination with pegaspargase for children with acute lymphoblastic leukemia. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Clofarabine (clofarabine)
• Cytarabine (high-dose) (cytarabine)
• Pegaspargase (pegaspargase)

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Leukemia | Phase 2, Phase 3 | Status: COMPLETED